INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Discretionary transactionVerified data

Morrone Louis H. reported ABT

EXECUTIVE VICE PRESIDENT · ABBOTT LABORATORIES · Common shares without par value

Side
I
Value
$1,296
Shares
12
Price
$107.99
Executed
Aug 12, 2026
Disclosed
Aug 13, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 12 executedAug 13, 2026 disclosed

ABT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
8/ 100 · ROUTINE
Methodology →
  • Transaction type+3 / 20

    Discretionary transaction

  • Relative size+1 / 25

    $1K reported value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ABT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    31
    Thomas H. Kean, Jr.RSelf
    ABTABBOTT LABORATORIES
    Partial sale
    		SELL$1,001 – $15KSep 17, 2026Oct 30, 2026
    traded Sep 17, 2026
    		+43dHOUSE PTR

    Evidence

    30
    Pete SessionsRSpouse
    ABTABBOTT LABORATORIES
    Sale
    		SELL$50K – $100KOct 2, 2026Oct 27, 2026
    traded Oct 2, 2026
    		+25dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    ABTABBOTT LABORATORIES
    Purchase
    		BUY$1,001 – $15KSep 18, 2026Oct 12, 2026
    traded Sep 18, 2026
    		+24dHOUSE PTR

    Evidence

    34
    Rick W. AllenRSpouse
    ABTABBOTT LABORATORIES
    Sale
    		SELL$15K – $50KJul 14, 2026Aug 18, 2026
    traded Jul 14, 2026
    		+35dHOUSE PTR

    Evidence

    37
    RM
    Richard Dean McCormickSelf
    ABTABBOTT LABORATORIES
    Sale
    		SELL$1,001 – $15KJul 30, 2026Aug 14, 2026
    traded Jul 30, 2026
    		+15dHOUSE PTR

    Evidence

    36
    MH
    Morrone Louis H.EXECUTIVE VICE PRESIDENT
    ABTABBOTT LABORATORIES
    Open-market sale
    		SELL$643K
    5,850 sh
    		Aug 11, 2026Aug 13, 2026
    traded Aug 11, 2026
    		+2dSEC FORM 4

    Evidence

    35
    Mike KellyRSpouse
    ABTABBOTT LABORATORIES
    Sale
    		SELL$1,001 – $15KJul 17, 2026Aug 12, 2026
    traded Jul 17, 2026
    		+26dHOUSE PTR

    Evidence

    30
    Rick LarsenDSelf
    ABTABBOTT LABORATORIES
    Sale
    		SELL$1,001 – $15KJul 8, 2026Jul 12, 2026
    traded Jul 8, 2026
    		+4dHOUSE PTR

    Evidence

    25
    RM
    Richard Dean McCormickSelf
    ABTABBOTT LABORATORIES
    Purchase
    		BUY$1,001 – $15KJun 12, 2026Jul 9, 2026
    traded Jun 12, 2026
    		+27dHOUSE PTR

    Evidence

    25
    RM
    Richard Dean McCormickSelf
    ABTABBOTT LABORATORIES
    Purchase
    		BUY$1,001 – $15KJun 12, 2026Jul 9, 2026
    traded Jun 12, 2026
    		+27dHOUSE PTR

    Evidence

    36
    Gilbert Ray Cisneros, Jr.DSelf
    ABTABBOTT LABORATORIES
    Purchase
    		BUY$1,001 – $15KJun 16, 2026Jul 2, 2026
    traded Jun 16, 2026
    		+16dHOUSE PTR

    Evidence

    21
    AN
    Ahuja NitaDirector
    ABTABBOTT LABORATORIES
    Grant or award
    		A$31K
    347 sh
    		Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    		+1dSEC FORM 4

    Evidence

    13
    GP
    Gonzalez Patricia PaolaDirector
    ABTABBOTT LABORATORIES
    Grant or award
    		A$33K
    363 sh
    		Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    		+1dSEC FORM 4

    Evidence

    8
    CC
    Cushman Elizabeth C.EVP, GC AND SECRETARY
    ABTABBOTT LABORATORIES
    Tax withholding
    		F$53K
    560 sh
    		Jun 27, 2026Jun 29, 2026
    traded Jun 27, 2026
    		+2dSEC FORM 4

    Evidence

    29
    Julie JohnsonDJoint
    ABTABBOTT LABORATORIES
    Sale
    		SELL$1,001 – $15KMay 12, 2026Jun 12, 2026
    traded May 12, 2026
    		+31dHOUSE PTR

    Evidence

    26
    Gilbert Ray Cisneros, Jr.DSelf
    ABTABBOTT LABORATORIES
    Sale
    		SELL$1,001 – $15KMay 15, 2026Jun 8, 2026
    traded May 15, 2026
    		+24dHOUSE PTR

    Evidence

    39
    Rick W. AllenRSpouse
    ABTABBOTT LABORATORIES
    Sale
    		SELL$15K – $50KApr 16, 2026Jun 5, 2026
    traded Apr 16, 2026
    		+50dHOUSE PTR

    Evidence

    25
    Josh GottheimerDJoint
    ABTABBOTT LABORATORIES
    Partial sale
    		SELL$1,001 – $15KMay 27, 2026Jun 3, 2026
    traded May 27, 2026
    		+7dHOUSE PTR

    Evidence

    26
    MK
    Moreland Mary KEXECUTIVE VICE PRESIDENT
    ABTABBOTT LABORATORIES
    Discretionary transaction
    		I$502K
    5,314 sh
    		Apr 28, 2026Apr 29, 2026
    traded Apr 28, 2026
    		+1dSEC FORM 4

    Evidence

    17
    MW
    McDew Darren WDirector
    ABTABBOTT LABORATORIES
    Grant or award
    		A—
    2,286 sh
    		Apr 24, 2026Apr 28, 2026
    traded Apr 24, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001867666-26-000013
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 12, 2026
    Published
    Aug 13, 2026
    Ingested by INSIDER
    Nov 5, 02:23 UTC
    Last re-read
    Nov 5, 02:23 UTC

    Extracted facts

    Filer
    Morrone Louis H.
    Role
    EXECUTIVE VICE PRESIDENT
    Transaction
    Discretionary transactionAs filed: “I”
    Asset
    ABBOTT LABORATORIES
    Ticker
    ABT
    Shares
    12
    Price per share
    $107.99
    Value
    $1,296
    Execution date (reported)
    Aug 12, 2026
    Owned after transaction
    0 shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 12
    • Price: $107.99

    = $1,296

    What this establishes

    Morrone Louis H. filed this Form 4 reporting a discretionary transaction of ABT on Aug 12, 2026. It became public on Aug 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EXECUTIVE VICE PRESIDENT
    Morrone Louis H.cik:0001867666
    Issuer
    ABBOTT LABORATORIEScik:0000001800

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.